| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AMERICAN ORIENTAL BIOENGINEERING Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRATEC | 22,750 | -1,09 % | Stratec Aktie: mwb stuft hoch, aber ... | Nach einem Kursrückgang von mehr als 14 Prozent vom jüngsten Hoch stuft mwb research die Stratec Aktie von "Sell" auf "Hold" hoch und erhöht das Kursziel von 21 auf 22 Euro. Beim aktuellen XETRA-Kurs... ► Artikel lesen | |
| CYTOSORBENTS | 5,350 | 0,00 % | WBB Securities initiates CytoSorbents stock with Speculative Buy | ||
| BRIGHTSPRING HEALTH SERVICES | 62,36 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 55,82 | 0,00 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| AVEANNA HEALTHCARE | 12,990 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,330 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 39,110 | +0,03 % | Stephens initiates Concentra stock with overweight on health model | ||
| FRESENIUS | 45,345 | -0,55 % | Fresenius beruft neuen Vorstand für Kabi - CFO-Vertrag verlängert | DJ Fresenius beruft neuen Vorstand für Kabi - CFO-Vertrag verlängert
DOW JONES--Fresenius bekommt einen neuen Vorstand für die Sparte Kabi. Wie das DAX-Unternehmen mitteilte, hat der Aufsichtsrat... ► Artikel lesen | |
| BETA BIONICS | 18,390 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,445 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Plan to Nye County for 2027 | ||
| BILLIONTOONE | 104,58 | -0,09 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,750 | +0,10 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für Siemens Healthineers von 45 auf 48 Euro angehoben und die Einstufung auf "Outperform" belassen. Der Start des neuen Strahlentherapiesystems... ► Artikel lesen | |
| GENEDX | 68,95 | +0,01 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| STARLING ONCOLOGY INSTITUTE | 6,830 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| PROGYNY | 28,440 | 0,00 % | Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report |